VIVO News and Press, Meridian Bioscience Inc. From 09/16/21

The following slide deck was published by Meridian Bioscience, Inc. in conjunction with this event. For further details see: Meridian Bioscience (VIVO) Presents 23rd Annual Global Investment Virtual Conference - Slideshow

CINCINNATI, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its Air-Dryable™ Direct DNA ...

CINCINNATI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Saliva and Air-Dryable™ Direct RNA/DNA qPCR Sa...

CINCINNATI, OH / ACCESSWIRE / September 1, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. ("Magellan"), expanded the Class I recall of its LeadC...

CINCINNATI, OH / ACCESSWIRE / August 30, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H. C. Wainwright 23rd Annual Global Investment Conference. Jack Kenny, Chief Executive ...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. About XLV. A list of cheap stocks. For further details see: XLV: Healthcare Dashboard For August

Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q3 2021 Earnings Call Aug 6, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: Meridian Bioscience Inc (VIVO) Q3 2021 Earnings Call Transcript

Meridian Bioscience, Inc. (VIVO) Q3 2021 Earnings Conference Call August 06, 2021 10:00 AM ET Company Participants Charles Wood - Vice President of Corporate Strategy, Business Development and Investor Relations John Kenny - Chief Executive Officer Bryan Baldasare - Executive Vice President a...

The following slide deck was published by Meridian Bioscience, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Meridian Bioscience, Inc. 2021 Q3 - Results - Earnings Call Presentation

Meridian Bioscience (NASDAQ:VIVO): FQ3 Non-GAAP EPS of $0.22 misses by $0.09; GAAP EPS of $0.27 misses by $0.05. Revenue of $63.51M (-25.1% Y/Y) misses by $9.61M. Press Release For further details see: Meridian Bioscience EPS misses by $0.09, misses on revenue